Regeneron Misses On Q4 Earnings & Sales, View Bleak
February 09, 2017 at 14:54 PM EST
Regeneron Pharmaceuticals, Inc., reported fourth-quarter 2016 earnings of $2.19 per share, missing the Zacks Consensus Estimate of $2.51 and were down from $0.94 reported in the year-ago quarter.
